English Français
RESOURCES

News

Explore our latest corporate news, events and press releases.

Author avatar for Larka Advises Partners Group On Its Acquisition Of FairJourney Biologics
Merger & Acquisition
Larka Advises Partners Group On Its Acquisition Of FairJourney Biologics
Larka is pleased to announce it performed the Commercial Due Diligence for Partners Group—supporting its acquisition of FairJourney Biologics, a leading antibody discovery Contract Research Organization (CRO).
Wed Jul 03 2024
Author avatar for Larka Advises Motion Equity On Its Acquisition Of Banook
Merger & Acquisition
Larka Advises Motion Equity On Its Acquisition Of Banook
Larka is delighted to announce it acted as the buy-side Commercial Due Diligence advisor for Motion Equity Partners—supporting its acquisition of Banook, a leading French Central Service Provider.
Fri Nov 03 2023
Author avatar for Larka Performs 4 Sourcing Processes for Global BioPharma Clients.
Tech Ops & Outsourcing
Larka Performs 4 Sourcing Processes for Global BioPharma Clients.
Leveraging Lensource®, Larka enabled the identification and selection of CRO, CDMO and CMO partners for 4 major Biotech & Pharma clients, including...
Mon Oct 23 2023
Author avatar for CMO Sourcing Process for Juvisé Pharmaceuticals
Tech Ops & Outsourcing
CMO Sourcing Process for Juvisé Pharmaceuticals
Juvisé Pharmaceuticals leveraged Larka’s Lensource® solution for the identification, assessment and selection of a Contract Manufacturing Organisation (CMO) partner to supply one of its commercial products.
Mon May 15 2023
Author avatar for Larka Advises Biose Industrie, Acquired by L-GAM & the French State
Merger & Acquisition
Larka Advises Biose Industrie, Acquired by L-GAM & the French State
Larka is delighted to announce it acted as the sell-side Vendor Commercial Due Diligence provider to support the sale process of Biose Industrie—a world-leading Contract Development and Manufacturing Organisation (CDMO)—acquired by L-GAM & the French State.
Fri Mar 17 2023
Author avatar for Larka Advises Apax Partners On Its Acquisition Of Porsolt
Merger & Acquisition
Larka Advises Apax Partners On Its Acquisition Of Porsolt
Larka is delighted to announce it acted as the buy-side Commercial Due Diligence advisor for Apax Partners, supporting its acquisition of Porsolt, a leading French Contract Research Organization (CRO).
Wed Mar 08 2023
Author avatar for Larka Supports Albumedix' Sale Process, Acquired by Sartorius
Merger & Acquisition
Larka Supports Albumedix' Sale Process, Acquired by Sartorius
Larka is delighted to announce it acted as the sell-side Vendor Commercial Due Diligence provider to support the sale process of Albumedix – a leading recombinant albumin-based solution provider based in Nottingham, UK – acquired by the Sartorius Group.
Wed Oct 26 2022
Author avatar for Larka Advises Keensight on CRO Axxam Acquisition
Merger & Acquisition
Larka Advises Keensight on CRO Axxam Acquisition
Larka is delighted to announce it acted as the buy-side Commercial Due Diligence provider to support Keensight Capital on its acquisition of a majority stake in Axxam, a global-leading Contract Research Organization (CRO) based in Italy.
Thu Sep 01 2022
Author avatar for Larka Advises Cathay on its Investment in CRO Transcure
Merger & Acquisition
Larka Advises Cathay on its Investment in CRO Transcure
Larka is thrilled to announce it performed the Commercial Due Diligence to support Cathay Capital’s investment in TransCure bioServices, a global-leading Contract Research Organization (CRO) based in France.
Wed Aug 31 2022
Author avatar for Larka Advises Merieux Equity Partners on its investment in Janvier Labs
Merger & Acquisition
Larka Advises Merieux Equity Partners on its investment in Janvier Labs
Larka provides Merieux Equity Partners with a Commercial Due Diligence to support its investment in French BioPharma company Janvier Labs.
Tue Jul 26 2022
Author avatar for Larka Advises Elyan on CRO Oncodesign Acquisition Process
Merger & Acquisition
Larka Advises Elyan on CRO Oncodesign Acquisition Process
Larka provides Elyan Partners with a Commercial Due Diligence to support the acquisition of CRO services Business Unit of Oncodesign, a leading French BioPharma company.
Mon Jul 11 2022
Author avatar for Larka Advises Gimv on CDMO BioConnection Investment Deal
Merger & Acquisition
Larka Advises Gimv on CDMO BioConnection Investment Deal
Larka provides Gimv with a Technical Due Diligence and Operational Due Diligence to support its investment in leading Dutch bio-CDMO BioConnection.
Tue May 24 2022
Author avatar for Interview with: Yana Marmann
Our People
Interview with: Yana Marmann
Fresh out of college and hired amid the COVID-19 pandemic, Yana saw in Larka an opportunity to shape a career within the BioPharma industry while evolving in a fast-paced and exciting environment.
Mon Apr 25 2022
Author avatar for Vendor Due Diligence for Afinum and SHS | evitria
Merger & Acquisition
Vendor Due Diligence for Afinum and SHS | evitria
Larka is very pleased to announce that it’s M&A Unit performed the Vendor Commercial Due-Diligence to support Afinum’s exit process of evitria, a global leading service provider specialized in transient antibody expression.
Tue Jul 27 2021
Author avatar for Commercial Due Diligence for Keensight Capital | Symeres
Merger & Acquisition
Commercial Due Diligence for Keensight Capital | Symeres
Larka is very proud to announce that it performed the Commercial-Due-Diligence for Keensight Capital on its acquisition of Symeres.
Mon Jun 07 2021
Author avatar for Commercial Due Diligence for Clean Biologics & Archimed | Biodextris
Merger & Acquisition
Commercial Due Diligence for Clean Biologics & Archimed | Biodextris
Larka is pleased to announce that it performed the Commercial Due-Diligence for Clean Biologics group – backed by Archimed - on their acquisition of Biodextris.
Tue May 11 2021
Author avatar for New Office
Corporate News
New Office
As a result of a strong and continued growth in recent years, we are delighted to announce the opening of our new office in Nice.
Sun Aug 09 2020
Author avatar for Integrated Due Diligence for Cathay Capital | Biose
Merger & Acquisition
Integrated Due Diligence for Cathay Capital | Biose
Larka is pleased to announce that it performed the Commercial Due-Diligence, Operational Due-Diligence and Technical Due-Diligence for Cathay Capital.
Mon Jul 20 2020
Author avatar for Integrated Due Diligence for Keensight Capital | 3P Biopharmaceuticals
Merger & Acquisition
Integrated Due Diligence for Keensight Capital | 3P Biopharmaceuticals
Larka is pleased to announce that it performed the Commercial Due-Diligence, Operational Due-Diligence and Technical Due-Diligence for Keensight Capital.
Tue Jul 30 2019
Author avatar for Integrated Due Diligence for Archimed | Clean Cells
Report
Integrated Due Diligence for Archimed | Clean Cells
Larka is pleased to announce that it performed the Commercial Due-Diligence, Operational Due-Diligence and Technical Due-Diligence for Archimed.
Mon Dec 03 2018
Author avatar for Integrated Due Diligence for Keensight Capital & ERES | Biovian
Merger & Acquisition
Integrated Due Diligence for Keensight Capital & ERES | Biovian
Larka is pleased to announce that it performed the Commercial Due-Diligence, Operational Due-Diligence and Technical Due-Diligence for Keensight Capital and ERES, the new shareholders of Biovian.
Thu May 24 2018

Ready to talk?

Get in touch with our industry experts.

Contact us